Update: 09.08.2022
Last week: 30 week 2022 (25.07.2022 - 31.07.2022)
Last full month: July 2022
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 105 912 | 0.9% | 6.1% | 0 | 20 582 846 | 0.8% | 5.6% | -0.1 | 1.5% |
| MoM | 467 964 | -5.9% | 6.2% | 0.9 | 91 081 370 | -7.9% | 5.7% | 0.8 | -19.4% |
| YTD | 6 509 408 | 20.5% | 6.0% | 0.5 | 1 285 777 336 | 42.6% | 5.7% | 0.8 | 10.7% |
| MAT | 14 377 832 | 41.6% | 6.6% | 1.5 | 2 674 750 336 | 66.5% | 6.1% | 1.6 | 9.3% |
| DEXALGIN | |||||||||
| WoW | 26 748 | 2.0% | 0.7% | 0 | 11 519 914 | 2.4% | 1.9% | 0.1 | 0.2% |
| MoM | 117 256 | -6.4% | 0.7% | 0 | 50 089 782 | -6.6% | 1.8% | 0 | -3.7% |
| YTD | 1 172 262 | 25.9% | 0.8% | 0.1 | 486 338 928 | 37.7% | 2.1% | 0.3 | 6.5% |
| MAT | 2 080 263 | 10.4% | 0.8% | 0 | 834 034 437 | 19.0% | 2.1% | 0.1 | 3.7% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 70 477 | -1.2% | 53.4% | -2.2 | 35 773 180 | -1.3% | 58.1% | -3.3 | 2.9% |
| MoM | 318 430 | -5.2% | 55.8% | -1 | 161 646 972 | -6.1% | 61.2% | -1.4 | -3.6% |
| YTD | 3 019 554 | 5.6% | 58.4% | -8.1 | 1 523 199 031 | 19.0% | 63.8% | -6.2 | 20.3% |
| MAT | 5 442 226 | 9.1% | 61.2% | -4.8 | 2 667 649 081 | 23.9% | 66.7% | -3.3 | 17.6% |
| ESPUMISAN BABY | |||||||||
| WoW | 22 559 | -2.0% | 36.8% | -0.9 | 14 340 588 | -2.3% | 49.6% | -0.9 | 0.3% |
| MoM | 100 138 | -6.9% | 37.7% | -1.4 | 63 444 221 | -5.9% | 50.6% | -1.3 | -3.4% |
| YTD | 903 275 | -5.6% | 38.9% | -3 | 556 977 734 | 0.9% | 52.4% | -4.5 | 1.6% |
| MAT | 1 610 153 | -7.7% | 39.7% | -1.5 | 976 354 881 | 1.2% | 53.5% | -1.5 | -4.2% |
| FASTUM | |||||||||
| WoW | 15 285 | -3.9% | 1.0% | 0 | 8 132 833 | -3.0% | 2.3% | -0.1 | -1.9% |
| MoM | 71 372 | -12.0% | 1.1% | 0 | 37 717 439 | -10.8% | 2.4% | 0 | -14.1% |
| YTD | 692 571 | -13.1% | 1.2% | -0.2 | 351 801 656 | -4.0% | 2.6% | -0.4 | 2.7% |
| MAT | 1 280 849 | -12.4% | 1.3% | -0.2 | 625 455 229 | -4.4% | 2.8% | -0.3 | 0.9% |
| IODOMARIN | |||||||||
| WoW | 50 149 | 2.5% | 21.9% | 0.8 | 9 838 637 | 1.8% | 9.9% | 0.4 | -1.1% |
| MoM | 215 761 | -8.7% | 21.2% | 0.4 | 43 032 457 | -12.6% | 9.6% | -0.2 | -10.6% |
| YTD | 1 746 280 | 7.4% | 18.6% | -0.1 | 352 485 995 | 15.1% | 8.5% | 0 | 8.1% |
| MAT | 3 286 607 | 21.2% | 20.4% | 2.3 | 638 618 859 | 22.6% | 9.3% | 0.8 | 7.4% |
| LIOTON | |||||||||
| WoW | 22 156 | -0.2% | 2.3% | 0 | 22 591 646 | -0.9% | 4.7% | 0.1 | -2.2% |
| MoM | 101 978 | -9.4% | 2.4% | 0 | 105 289 953 | -11.3% | 4.7% | 0 | -9.5% |
| YTD | 866 045 | -15.3% | 2.5% | -0.3 | 876 933 101 | 6.7% | 4.9% | -0.5 | -4.7% |
| MAT | 1 535 270 | -11.9% | 2.6% | -0.2 | 1 458 116 765 | 7.1% | 5.2% | -0.3 | -5.4% |
| MEZYM | |||||||||
| WoW | 282 644 | -2.3% | 26.8% | -0.3 | 43 829 306 | -2.0% | 19.0% | -0.5 | -1.2% |
| MoM | 1 268 153 | -0.1% | 27.4% | 1 | 195 815 455 | 1.4% | 19.8% | 1.3 | -3.9% |
| YTD | 12 469 813 | 23.1% | 29.3% | 3.4 | 1 909 236 961 | 33.3% | 21.1% | 1.6 | 8.7% |
| MAT | 23 101 555 | 26.3% | 30.9% | 4.1 | 3 385 260 446 | 32.4% | 22.4% | 2 | 9.5% |
| MIG 400 | |||||||||
| WoW | 132 299 | -0.5% | 3.5% | 0 | 15 447 105 | -0.4% | 2.5% | 0 | 0.2% |
| MoM | 595 570 | -7.5% | 3.6% | -0.1 | 69 690 474 | -8.5% | 2.6% | -0.1 | -3.7% |
| YTD | 5 274 873 | 3.3% | 3.5% | -0.1 | 618 332 438 | 6.2% | 2.7% | -0.3 | 6.5% |
| MAT | 10 057 936 | 11.6% | 3.7% | 0.3 | 1 152 929 758 | 14.1% | 2.9% | 0.1 | 3.7% |
| PROSTAMOL | |||||||||
| WoW | 20 796 | -1.9% | 17.5% | -0.5 | 28 762 145 | -2.0% | 18.1% | -0.6 | 0.9% |
| MoM | 93 730 | -9.6% | 17.9% | -0.4 | 129 382 622 | -10.4% | 18.8% | -0.8 | -7.6% |
| YTD | 1 042 873 | -12.3% | 20.6% | -4 | 1 463 914 573 | -1.3% | 22.0% | -5 | 4.8% |
| MAT | 1 994 086 | -5.1% | 22.3% | -2.1 | 2 680 532 877 | 3.5% | 23.8% | -3 | 3.9% |
| RESPERO MYRTOL | |||||||||
| WoW | 10 807 | 5.7% | 8.6% | 0.5 | 4 996 904 | 5.1% | 8.4% | 0.5 | -0.4% |
| MoM | 44 155 | -22.5% | 7.9% | 0.4 | 20 644 482 | -23.6% | 7.8% | 0.5 | -26.4% |
| YTD | 753 230 | 194.2% | 9.1% | 5.7 | 350 769 358 | 184.7% | 8.8% | 4.9 | 9.8% |
| MAT | 1 244 039 | 115.1% | 8.1% | 3.9 | 572 431 943 | 103.6% | 7.9% | 3.1 | 10.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 6 509 408 | 20.5% | 6.0% | 0.5 | 1 285 777 336 | 42.6% | 5.7% | 0.8 | 10.7% |
| DEXALGIN | 1 172 262 | 25.9% | 0.8% | 0.1 | 486 338 928 | 37.7% | 2.1% | 0.3 | 6.5% |
| ESPUMISAN (ADULTS) | 3 019 554 | 5.6% | 58.4% | -8.1 | 1 523 199 031 | 19.0% | 63.8% | -6.2 | 20.3% |
| ESPUMISAN BABY | 903 275 | -5.6% | 38.9% | -3 | 556 977 734 | 0.9% | 52.4% | -4.5 | 1.6% |
| FASTUM | 692 571 | -13.1% | 1.2% | -0.2 | 351 801 656 | -4.0% | 2.6% | -0.4 | 2.7% |
| IODOMARIN | 1 746 280 | 7.4% | 18.6% | -0.1 | 352 485 995 | 15.1% | 8.5% | 0 | 8.1% |
| LIOTON | 866 045 | -15.3% | 2.5% | -0.3 | 876 933 101 | 6.7% | 4.9% | -0.5 | -4.7% |
| MEZYM | 12 469 813 | 23.1% | 29.3% | 3.4 | 1 909 236 961 | 33.3% | 21.1% | 1.6 | 8.7% |
| MIG 400 | 5 274 873 | 3.3% | 3.5% | -0.1 | 618 332 438 | 6.2% | 2.7% | -0.3 | 6.5% |
| PROSTAMOL | 1 042 873 | -12.3% | 20.6% | -4 | 1 463 914 573 | -1.3% | 22.0% | -5 | 4.8% |
| RESPERO MYRTOL | 753 230 | 194.2% | 9.1% | 5.7 | 350 769 358 | 184.7% | 8.8% | 4.9 | 9.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 14 377 832 | 41.6% | 6.6% | 1.5 | 2 674 750 336 | 66.5% | 6.1% | 1.6 | 9.3% |
| DEXALGIN | 2 080 263 | 10.4% | 0.8% | 0 | 834 034 437 | 19.0% | 2.1% | 0.1 | 3.7% |
| ESPUMISAN (ADULTS) | 5 442 226 | 9.1% | 61.2% | -4.8 | 2 667 649 081 | 23.9% | 66.7% | -3.3 | 17.6% |
| ESPUMISAN BABY | 1 610 153 | -7.7% | 39.7% | -1.5 | 976 354 881 | 1.2% | 53.5% | -1.5 | -4.2% |
| FASTUM | 1 280 849 | -12.4% | 1.3% | -0.2 | 625 455 229 | -4.4% | 2.8% | -0.3 | 0.9% |
| IODOMARIN | 3 286 607 | 21.2% | 20.4% | 2.3 | 638 618 859 | 22.6% | 9.3% | 0.8 | 7.4% |
| LIOTON | 1 535 270 | -11.9% | 2.6% | -0.2 | 1 458 116 765 | 7.1% | 5.2% | -0.3 | -5.4% |
| MEZYM | 23 101 555 | 26.3% | 30.9% | 4.1 | 3 385 260 446 | 32.4% | 22.4% | 2 | 9.5% |
| MIG 400 | 10 057 936 | 11.6% | 3.7% | 0.3 | 1 152 929 758 | 14.1% | 2.9% | 0.1 | 3.7% |
| PROSTAMOL | 1 994 086 | -5.1% | 22.3% | -2.1 | 2 680 532 877 | 3.5% | 23.8% | -3 | 3.9% |
| RESPERO MYRTOL | 1 244 039 | 115.1% | 8.1% | 3.9 | 572 431 943 | 103.6% | 7.9% | 3.1 | 10.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 105 912 | 0.9% | 6.1% | 0 | 20 582 846 | 0.8% | 5.6% | -0.1 | 1.5% |
| DEXALGIN | 26 748 | 2.0% | 0.7% | 0 | 11 519 914 | 2.4% | 1.9% | 0.1 | 0.2% |
| ESPUMISAN (ADULTS) | 70 477 | -1.2% | 53.4% | -2.2 | 35 773 180 | -1.3% | 58.1% | -3.3 | 2.9% |
| ESPUMISAN BABY | 22 559 | -2.0% | 36.8% | -0.9 | 14 340 588 | -2.3% | 49.6% | -0.9 | 0.3% |
| FASTUM | 15 285 | -3.9% | 1.0% | 0 | 8 132 833 | -3.0% | 2.3% | -0.1 | -1.9% |
| IODOMARIN | 50 149 | 2.5% | 21.9% | 0.8 | 9 838 637 | 1.8% | 9.9% | 0.4 | -1.1% |
| LIOTON | 22 156 | -0.2% | 2.3% | 0 | 22 591 646 | -0.9% | 4.7% | 0.1 | -2.2% |
| MEZYM | 282 644 | -2.3% | 26.8% | -0.3 | 43 829 306 | -2.0% | 19.0% | -0.5 | -1.2% |
| MIG 400 | 132 299 | -0.5% | 3.5% | 0 | 15 447 105 | -0.4% | 2.5% | 0 | 0.2% |
| PROSTAMOL | 20 796 | -1.9% | 17.5% | -0.5 | 28 762 145 | -2.0% | 18.1% | -0.6 | 0.9% |
| RESPERO MYRTOL | 10 807 | 5.7% | 8.6% | 0.5 | 4 996 904 | 5.1% | 8.4% | 0.5 | -0.4% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 467 964 | -5.9% | 6.2% | 0.9 | 91 081 370 | -7.9% | 5.7% | 0.8 | -19.4% |
| DEXALGIN | 117 256 | -6.4% | 0.7% | 0 | 50 089 782 | -6.6% | 1.8% | 0 | -3.7% |
| ESPUMISAN (ADULTS) | 318 430 | -5.2% | 55.8% | -1 | 161 646 972 | -6.1% | 61.2% | -1.4 | -3.6% |
| ESPUMISAN BABY | 100 138 | -6.9% | 37.7% | -1.4 | 63 444 221 | -5.9% | 50.6% | -1.3 | -3.4% |
| FASTUM | 71 372 | -12.0% | 1.1% | 0 | 37 717 439 | -10.8% | 2.4% | 0 | -14.1% |
| IODOMARIN | 215 761 | -8.7% | 21.2% | 0.4 | 43 032 457 | -12.6% | 9.6% | -0.2 | -10.6% |
| LIOTON | 101 978 | -9.4% | 2.4% | 0 | 105 289 953 | -11.3% | 4.7% | 0 | -9.5% |
| MEZYM | 1 268 153 | -0.1% | 27.4% | 1 | 195 815 455 | 1.4% | 19.8% | 1.3 | -3.9% |
| MIG 400 | 595 570 | -7.5% | 3.6% | -0.1 | 69 690 474 | -8.5% | 2.6% | -0.1 | -3.7% |
| PROSTAMOL | 93 730 | -9.6% | 17.9% | -0.4 | 129 382 622 | -10.4% | 18.8% | -0.8 | -7.6% |
| RESPERO MYRTOL | 44 155 | -22.5% | 7.9% | 0.4 | 20 644 482 | -23.6% | 7.8% | 0.5 | -26.4% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"## [1] "ESPUMISAN (ADULTS)"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"## [1] "ESPUMISAN BABY"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"## [1] "FASTUM"## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"## [1] "LIOTON"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"## [1] "MEZYM"## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS #20"## [1] "MEZYM FORTE COATED TABLETS #20"## [1] "MEZYM FORTE COATED TABLETS #80"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS #20"## [1] "DEXALGIN"## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"## [1] "MIG 400"## [1] "MIG 400 COATED TABLETS 400 MG #10"## [1] "MIG 400 COATED TABLETS 400 MG #20"## [1] "PROSTAMOL"## [1] "PROSTAMOL UNO CAPS 320 MG #30"## [1] "PROSTAMOL UNO CAPS 320 MG #60"## [1] "PROSTAMOL UNO CAPS 320 MG #90"## [1] "IODOMARIN"## [1] "IODOMARIN 100 TABS 100 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #50"## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"## [1] "RESPERO MYRTOL"## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs